首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
【2h】

Ultraviolet-induced p53 mutations in atypical fibroxanthoma.

机译:紫外线诱发的非典型纤维性黄瘤中的p53突变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atypical fibroxanthoma (AFX) is an uncommon neoplasm of the superficial soft tissue occurring in actinically damaged skin of elderly patients. Sun-exposed skin also represents the main site of squamous and basal cell carcinomas and malignant melanoma, and a key role for ultraviolet (UV) radiation in their pathogenesis has long been suspected. UV-related mutations of the p53 gene have been identified in human skin cancers. To verify whether the pathogenesis of AFX is related to the effect of sunlight, p53 protein and gene status have been investigated in a series of 10 cases of AFX. Seven of 10 showed p53 immunoreactivity in most of the neoplastic cells. Molecular analysis of the p53 gene revealed an abnormal single strand conformation polymorphism pattern in all the p53 positive cases. Polymerase chain reaction direct sequencing revealed that all the mutations involved cytosine bases. Four cases showed C to T transitions (including two CC-TT double base substitutions) and two cases showed C to G transversion. All but one mutation took place at dipyrimidine sites. These findings provide the first objective evidence for the central role of UV radiation in the development of AFX and also represent the first in vivo demonstration of solar UV-induced mutations in a human mesenchymal neoplasm.
机译:非典型纤维性黄瘤(AFX)是一种浅表软组织肿瘤,发生在老年患者的光化性受损皮肤中。暴露于阳光下的皮肤也代表了鳞状和基底细胞癌和恶性黑色素瘤的主要部位,长期以来人们一直怀疑紫外线(UV)在其发病机理中起着关键作用。在人类皮肤癌中已经鉴定出p53基因的紫外线相关突变。为了验证AFX的发病机理是否与日光的影响有关,在一系列10例AFX病例中研究了p53蛋白和基因状态。 10个中的7个在大多数肿瘤细胞中显示出p53免疫反应性。对p53基因的分子分析显示,在所有p53阳性病例中,单链构象多态性均异常。聚合酶链反应直接测序表明,所有突变均涉及胞嘧啶碱基。 4例显示C到T转换(包括两个CC-TT双碱基取代),而2例显示C到G转换。除一个突变外,所有突变均发生在嘧啶嘧啶位点。这些发现为紫外线辐射在AFX发生中的重要作用提供了第一个客观证据,也代表了人类间质肿瘤中太阳紫外线诱导的突变的首次体内证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号